Habituation of Aggression in Mice: Pharmacological Evidence of Catecholaminergic and Serotonergic Mediation
Overview
Authors
Affiliations
A pharmacological study was undertaken to evaluate the role of catecholamines and serotonin in the mediation of aggression. The dose-effect relationship of d-amphetamine, apomorphine, methysergide, lisuride, and the time-dependent effects of 10 mg/kg p-chloroamphetamine (PCA) were determined on aggressive behavior in a habituation paradigm. The frequency of attacks and sideways threats exponentially declined in ten consecutive confrontations between resident and intruder mice, and recovered when a new intruder was introduced. d-Amphetamine (0.1-5.0 mg/kg) and apomorphine (0.03-1.0 mg/kg), administered IP 5 min before the first confrontation, attenuated the usual decline of attack and threat in subsequent trials. PCA enhanced attack, sideways threat, and locomotion at day 1 after injection. Methysergide (1, 3, 10 mg/kg) and lisuride (0.03, 0.3, 1.0 mg/kg) suppressed all activity, including locomotion and aggression. The data support the hypothesis that catecholamines mediate the activation of aggression, but do not indicate an inhibitory role for serotonin. Aggression in the resident-intruder paradigm appears to require intact serotonin activity.
Neuroinflammation, Early-Life Adversity, and Brain Development.
Andersen S Harv Rev Psychiatry. 2022; 30(1):24-39.
PMID: 34995033 PMC: 8820591. DOI: 10.1097/HRP.0000000000000325.
Wang L, Simms J, Peters C, Tynan-La Fontaine M, Li K, Gill T J Neurosci. 2019; 39(36):7102-7117.
PMID: 31320449 PMC: 6733546. DOI: 10.1523/JNEUROSCI.3137-18.2019.
The Urge to Fight: Persistent Escalation by Alcohol and Role of NMDA Receptors in Mice.
Covington 3rd H, Newman E, Tran S, Walton L, Hayek W, Leonard M Front Behav Neurosci. 2018; 12:206.
PMID: 30271332 PMC: 6146040. DOI: 10.3389/fnbeh.2018.00206.
Ito W, Huang H, Brayman V, Morozov A Genes Brain Behav. 2018; 18(1):e12513.
PMID: 30120813 PMC: 6342662. DOI: 10.1111/gbb.12513.
Vanaveski T, Narvik J, Innos J, Philips M, Ottas A, Plaas M Front Neurosci. 2018; 12:399.
PMID: 29946233 PMC: 6005828. DOI: 10.3389/fnins.2018.00399.